ARCHIVES

Conferees Set $1.991 Bil. NCI Budget, Ax Earmark For Breast Cancer, But Find $210 Mil. In Defense

This article is from The Cancer Letter archive.

Vol. 18 No. 39 | October 9, 1992

Download PDF Visit The Full Archive

Related Articles

Doctor’s Allegation Of Drug Safety Problem Starts Controversy With Manufacturer

May 5, 1995

O’Shaughnessy, Burris To Present for Genentech At FDA Hearing At June 28-29

June 10, 2011

Federal Coordinating Council On Comparative Effectiveness Research To Hold Meeting

April 10, 2009

Manipulating The Therapeutic Index Clinical Trials Goal: Hellman

June 13, 1980

Over Half of ALK-Positive NSCLC Patients Responded To Crizotinib In Colorado Study

November 26, 2010

DCT Board Ok’s concept For In Vivo Combination Studies

November 23, 1990